KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Liabilities and Shareholders Equity (2016 - 2025)

Historic Liabilities and Shareholders Equity for Medpace Holdings (MEDP) over the last 11 years, with Q4 2025 value amounting to $2.0 billion.

  • Medpace Holdings' Liabilities and Shareholders Equity fell 596.87% to $2.0 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $7.2 billion, marking a year-over-year decrease of 890.09%. This contributed to the annual value of $2.0 billion for FY2025, which is 596.87% down from last year.
  • Medpace Holdings' Liabilities and Shareholders Equity amounted to $2.0 billion in Q4 2025, which was down 596.87% from $1.8 billion recorded in Q3 2025.
  • Medpace Holdings' Liabilities and Shareholders Equity's 5-year high stood at $2.1 billion during Q4 2024, with a 5-year trough of $1.3 billion in Q2 2022.
  • In the last 5 years, Medpace Holdings' Liabilities and Shareholders Equity had a median value of $1.6 billion in 2021 and averaged $1.6 billion.
  • Its Liabilities and Shareholders Equity has fluctuated over the past 5 years, first crashed by 1852.12% in 2022, then surged by 4017.84% in 2024.
  • Medpace Holdings' Liabilities and Shareholders Equity (Quarter) stood at $1.7 billion in 2021, then decreased by 18.52% to $1.4 billion in 2022, then grew by 22.5% to $1.7 billion in 2023, then grew by 26.8% to $2.1 billion in 2024, then decreased by 5.97% to $2.0 billion in 2025.
  • Its last three reported values are $2.0 billion in Q4 2025, $1.8 billion for Q3 2025, and $1.6 billion during Q2 2025.